Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -39,507 | N/A | N/A | -50,187 | N/A |
| Depreciation Amortization | 3,210 | N/A | N/A | 5,529 | N/A |
| Accounts receivable | 100 | N/A | N/A | 2,210 | N/A |
| Accounts payable and accrued liabilities | 1,734 | N/A | N/A | -1,976 | N/A |
| Other Working Capital | 1,331 | N/A | N/A | -1,750 | N/A |
| Other Operating Activity | 1,843 | -21,299 | -8,827 | 1,108 | -33,563 |
| Operating Cash Flow | $-31,289 | $-21,299 | $-8,827 | $-45,066 | $-33,563 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -47,637 | -39,972 | 7,674 | 2,253 | 18,966 |
| PPE Investments | -530 | -381 | -181 | 425 | 409 |
| Net Acquisitions | N/A | N/A | N/A | 25,715 | 25,715 |
| Investing Cash Flow | $-48,167 | $-40,353 | $7,493 | $28,393 | $45,090 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 1,000 | 1,000 |
| Debt Repayment | -3,628 | -2,431 | -1,210 | -2,776 | -1,775 |
| Common Stock Issued | 71,620 | 70,209 | 70,045 | 28,010 | 1,033 |
| Other Financing Activity | 309 | 0 | 0 | 1,355 | -154 |
| Financing Cash Flow | $68,301 | $67,778 | $68,835 | $27,589 | $104 |
| Beginning Cash Position | 13,141 | 13,141 | 13,141 | 2,225 | 2,225 |
| End Cash Position | 1,986 | 19,267 | 80,642 | 13,141 | 13,856 |
| Net Cash Flow | $-11,155 | $6,126 | $67,501 | $10,916 | $11,631 |
| Free Cash Flow | |||||
| Operating Cash Flow | -31,289 | -21,299 | -8,827 | -45,066 | -33,563 |
| Capital Expenditure | -556 | -407 | -202 | -320 | -260 |
| Free Cash Flow | -31,845 | -21,706 | -9,029 | -45,386 | -33,823 |